Pura Vida Investments’s Acceleron Pharma XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-20,400
Closed -$1.94M 188
2020
Q2
$1.94M Sell
20,400
-56,281
-73% -$5.43M 0.19% 88
2020
Q1
$6.89M Buy
+76,681
New +$5.96M 0.82% 31

Pura Vida Investments's XLRN Position: Q3 2020 in Review

Pura Vida Investments sold out of Acceleron Pharma (XLRN) in Q3 2020, closing a stake of 20,400 shares — an estimated $1.94M sold.

Pura Vida Investments first reported a position in XLRN in Q1 2020 and held it in 2 quarters. The position peaked at $6.89M in Q1 2020. 238 funds tracked by Wall St. Rank hold XLRN as of Q3 2020.

  • Pura Vida Investments reported no remaining Acceleron Pharma position as of Q3 2020 after selling out during the quarter.
  • Pura Vida Investments sold 20,400 Acceleron Pharma shares in Q3 2020, an estimated $1.94M.
  • Pura Vida Investments first reported a position in Acceleron Pharma in Q1 2020 and held it in 2 quarters.
  • Pura Vida Investments's Acceleron Pharma position peaked at $6.89M in Q1 2020.
  • 238 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2020.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.